False
Previously, Jim as held the positions of Head of Research & Development and Head of Marketing of Carl Zeiss Meditec AG, and was the Chief Executive Officer and President of Carl Zeiss Meditec, Inc. until joining Oraya Therapeutics. A former US Navy submarine commander, Jim has had a wide range of management experiences, and brings them together in this column for The Ophthalmologist.
December 5, 2019
Electrical stimulation of neural responses can significantly improve outcomes for retinitis pigmentosa patients
1 min read
January 22, 2014
Change is hard – and major change even more so – in large part for one simple reason: as Leo Tolstoy once advised, “Everyone thinks of changing the world, but no one thinks of changing himself.”
1 min read
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False